丁威, 赵文婷, 张东峰. 结核分枝杆菌聚酮合成酶13抑制剂的研究进展J. 药学学报, 2020,55(8): 1768-1773. doi: 10.16438/j.0513-4870.2020-0213
引用本文: 丁威, 赵文婷, 张东峰. 结核分枝杆菌聚酮合成酶13抑制剂的研究进展J. 药学学报, 2020,55(8): 1768-1773. doi: 10.16438/j.0513-4870.2020-0213
DING Wei, ZHAO Wen-ting, ZHANG Dong-feng. Research advances in M. Tuberculosis polyketide synthase 13 inhibitorsJ. Acta Pharmaceutica Sinica, 2020,55(8): 1768-1773. doi: 10.16438/j.0513-4870.2020-0213
Citation: DING Wei, ZHAO Wen-ting, ZHANG Dong-feng. Research advances in M. Tuberculosis polyketide synthase 13 inhibitorsJ. Acta Pharmaceutica Sinica, 2020,55(8): 1768-1773. doi: 10.16438/j.0513-4870.2020-0213

结核分枝杆菌聚酮合成酶13抑制剂的研究进展

Research advances in M. Tuberculosis polyketide synthase 13 inhibitors

  • 摘要: 在结核分枝杆菌分枝菌酸的生物合成通路中,聚酮合成酶13(polyketide synthase 13,Pks13)起到最后一步的组装作用。通过抑制Pks13可以抑制分枝菌酸的合成,进而起到杀灭结核分枝杆菌的作用。目前已发现五类化学骨架不同的Pks13抑制剂,本文将简要介绍这几类Pks13抑制剂的发现过程、作用机制以及不同抑制剂的构效关系。

     

    Abstract: Polyketide synthase 13 (Pks13) performs a critical role in the final assembly step of mycolic acid synthesis in Mycobacterium tuberculosis. The inhibition of Pks13 can influence the biosynthesis of mycolic acid, which leads to Mycobacterium tuberculosis cell death. Researchers have discovered Pks13 inhibitors with five chemical scaffolds as antituberculosis agents. Herein, we summarize recent advances in the study of Pks13 inhibitors including the process of discovery, the mechanism of action and structure-activity relationships.

     

/

返回文章
返回